Skip to main content
. 2022 Aug 7;28(29):3934–3945. doi: 10.3748/wjg.v28.i29.3934

Table 3.

Association of the clinical outcomes in relation to the timing of biliary drainage and severity grading by Tokyo guidelines 2018

Severity of AC
Characteristic-median (IQR)
Drainage
Absence of drainage
P value
Drainage < 12 h
Drainage > 12 h or absence
P value
Drainage < 24 h
Drainage > 24 h or absence
P value
Drainage < 48 h
Drainage > 48 h or absence
P value
Grade I IHM 0/302 1/131 0.303 0/54 1/379 1.000 0/128 1/305 1.000 0/199 1/234 1.000
LOS (d) 11 (9-15) 7 (4-10) < 0.001 11 (8-13.25) 10 (8-14) 0.778 11 (8-14) 10 (7-14) 0.004 11 (8-14) 10 (6-14) 0.002
Survivors’ LOS (d) (n = 387) 12 (9-15) 8 (5-11) < 0.001 11 (8-13.25) 11 (8-14) 0.794 11 (9-14) 11 (8-14) 0.065 11 (9-14) 10 (8-14) 0.101
Hospitalization cost (CNY) 42845.67 (33734.18-52209.23) 15763.10 (7737.32-23680.31) < 0.001 43328.59 (32863.61-49384.19) 35317.71 (18848.59-46850.08 0.001 44154.19 (35638.76-52219.56) 31292.68 (16269.75-44599.67) < 0.001 42908.34 (33358.44-50564.68) 25519.43 (12347.06-42424.96) < 0.001
Survivors’ hospitalization cost (CNY) (n = 387) 42957.18 (33973.58-52224.73) 16596.85 (9096.73-24755.65 < 0.001 43462.72 (36174.00-49384.19) 36604.86 (21962.98-47554.27) 0.003 44443.3 (35988.02-52237.14) 33492.6 (46019.17-18880.26) < 0.001 43264.07 (34606.54-51093.62) 29762.32 (16376.75-44463.21) < 0.001
Grade II IHM 2/306 5/99 0.011 0/69 7/336 0.608 0/139 7/266 0.101 1/193 6/212 0.125
LOS (d) 11 (9-15) 7 (4-12) < 0.001 11 (8-14) 11 (7-14) 0.684 11 (9-14) 10 (7-14) 0.122 11 (8-14) 10 (7-14.8) 0.190
Survivors’ LOS (d) (n = 349) 12 (9-15) 7.5 (4.75-11.25) < 0.001 11.5 (9-14) 11 (8-14) 0.367 12 (10-14) 11 (7-14) 0.024 12 (9-14) 11 (7-14) 0.050
Hospitalization cost (CNY) 44033.13 (31071.05-56134.72) 17626.20 (10037.69-25587.43) < 0.001 45832.44 (36061.53-56949.37) 36132.93 (21795.89-51453.62) < 0.001 46789.09 (35989.59-57723.15) 31505.72 (19948.31-47463.61) < 0.001 45489.74 (33858.99-57600.43) 29275.30 (16928.45-46255.47) < 0.001
Survivors’ hospitalization cost (CNY) (n = 349) 45004.20 (32631.09-56660.62) 16342.15 (10300.68-25017.80) < 0.001 47938.00 (37937.29-58046.02) 36629.15 (22828.93-51509.37) < 0.001 48254.61 (37937.29-58929.51) 31589.96 (20386.80-47062.76) < 0.001 46564.37 (36191.07-57998.63) 29338.38 (17687.02-45685.12) < 0.001
Grade III IHM 11/307 22/160 < 0.001 3/89 30/378 0.168 7/178 26/289 0.041 9/225 24/242 0.018
LOS (d) 13 (9-17) 8 (3-12) < 0.001 13 (11-19) 11 (6-15) < 0.001 13 (10-17) 10 (6-14) < 0.001 13 (9-17) 9.5 (5-14) < 0.001
Survivors’ LOS (d) (n = 351) 13 (11-18) 9.5 (7-13.25) <0.001 13 (12-19) 12 (9-16) 0.001 13 (11-17.75) 12 (9-15) < 0.001 13 (11-17.75) 11 (8-15) < 0.001
Hospitalization cost 51583.64 (38985.47-64886.01) 20183.58 (11317.37-29525.99) < 0.001 56599.94 (43260.73-70300.00) 38527.58 (21034.79-55279.53) < 0.001 55121.49 (40428.29-67707.01) 31832.99 (17933.81-50037.89) < 0.001 54295.52 (39252.57-65638.57) 28165.23 (15708.29-45478.26) < 0.001
Survivors’ hospitalization cost (CNY) (n = 351) 53507.33 (41027.94-65312.29) 22909.77 (15594.93-31845.39) < 0.001 57976.4 (50131.44-70333.71) 43241.54 (28347.56-57860.29) < 0.001 55873.84 (46654.40-69946.73) 38973.06 (24292.41-53090.85) < 0.001 55782.38 (43994.26-66493.67) 34748.29 (21379.37-50147.24) < 0.001

AC: Acute cholangitis; IQR: Interquartile range; IHM: In-hospital mortality; LOS: Length of stay; CNY: Chinese Yuan.